Mit uns mehr bewirken
CHEPLAPHARM (cheplapharm.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 37th percentile of 11156 Healthcare brands.
CHEPLAPHARM Arzneimittel GmbH is a family-owned German pharmaceutical company headquartered in Greifswald, founded in 1998. It specializes in acquiring and distributing established, branded pharmaceutical products worldwide, aiming to ensure their long-term availability. The company positions itself as a reliable specialty pharma platform that combines economic success with ethical principles and patient welfare, serving patients, healthcare providers, investors, and prospective employees.
| Brand Name | CHEPLAPHARM |
|---|---|
| Domain | cheplapharm.com |
| Industry | Healthcare |
| Founded | 1998 |
| Headquarters | Greifswald |
| Main Competitors | Advanz Pharma (56/100), Recordati (75/100), STADA Arzneimittel (88/100), Teva Pharmaceutical Industries (86/100), Viatris (90/100), Grünenthal (78/100) |
Moz Domain Authority 33/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #748,682 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Die CHEPLAPHARM Arzneimittel GmbH ist ein familiengeführtes Pharmaunternehmen mit Hauptsitz in Deutschland, das weltweit Markenprodukte vertreibt." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is DE-only, limiting citation in English-language AI answers.
Detected tech stack: Nginx.
Social footprint: verified profiles on Instagram; no detected presence on X (Twitter), LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is CHEPLAPHARM?", Claude could identify the brand as of September 2026. CHEPLAPHARM is a German pharmaceutical company based in Greifswald that acquires and markets established, often off-patent branded pharmaceutical products from larger pharma companies, rather than developing new drugs itself. Best known for Acquiring and commercializing mature branded pharmaceutical products divested by big pharma companies.
When asked "Best brands similar to CHEPLAPHARM?", Claude would recommend CHEPLAPHARM as of September 2026. It's a well-known player in the pharma licensing and brand acquisition space, so it would come up naturally when discussing companies that buy and manage legacy drug portfolios.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CHEPLAPHARM's main competitors in Healthcare: Advanz Pharma (56/100), Recordati (75/100), STADA Arzneimittel (88/100), Teva Pharmaceutical Industries (86/100), Viatris (90/100).
Sources: Brand Analyzer scan
CHEPLAPHARM is a family-owned German pharmaceutical company headquartered in Greifswald, founded in 1998. It operates in the healthcare sector and distributes established branded pharmaceutical products worldwide.
Sources: CHEPLAPHARM official site
CHEPLAPHARM has limited AI-search visibility, scoring 38/100 on Brand Analyzer's AI visibility composite (visibility 28, trust 36, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CHEPLAPHARM official site
CHEPLAPHARM was founded in 1998. CHEPLAPHARM operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CHEPLAPHARM is headquartered in Greifswald. CHEPLAPHARM operates in the Healthcare category.
Sources: Wikidata
CHEPLAPHARM scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CHEPLAPHARM official site
CHEPLAPHARM acquires and distributes established, branded pharmaceutical products on a global scale, ensuring their continued availability to patients and healthcare providers. As a specialty pharma company, it focuses on maintaining supply of proven medicines rather than developing new drugs from scratch.
Sources: CHEPLAPHARM official site
CHEPLAPHARM can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CHEPLAPHARM official site
CHEPLAPHARM offers established, branded pharmaceutical products that it acquires and distributes globally. The company focuses on maintaining the availability of these existing medicines rather than developing new pharmaceutical compounds.
Sources: CHEPLAPHARM official site
CHEPLAPHARM is known for being a family-led German pharmaceutical company that secures the long-term global availability of established, branded pharmaceutical products, combining business growth with ethical and patient-focused principles.
Sources: CHEPLAPHARM official site
CHEPLAPHARM's offerings are used by patients and healthcare providers who rely on its established branded medicines. The company also engages investors interested in sustainable pharmaceutical business growth and prospective employees seeking careers in the pharmaceutical sector.
Sources: CHEPLAPHARM official site
CHEPLAPHARM scores 38/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CHEPLAPHARM has a weak AI-visibility profile at 38/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (28/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #748,682 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 33/100 and thin schema.org structured data. In a live check, Claude could already identify CHEPLAPHARM from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CHEPLAPHARM: Chemonics International (74/100), Chemify (74/100), CHG Healthcare (74/100), CHI St. Vincent (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.